English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsOpinionBiocon Biologics' success in biosimilars points to the future pathway for Indian pharma

    Biocon Biologics' success in biosimilars points to the future pathway for Indian pharma

    Biosimilars a huge opportunity, and also a challenge for Indian drugmakers

    Sundeep Khanna
    December 13, 2024 / 13:53 IST
    Biocon Biologics' success in biosimilars points to the future pathway for Indian pharma

    While generics have hogged their share of limelight, it is biologics of the kind that companies like Biocon Biologics are making that are the most exciting development in the space

    • PRO Panorama

      Moneycontrol Pro Panorama | Dovish Fed, but dot plot shows deep divisions

      Sep 18, 2025 / 03:16 PM IST

      For Moneycontrol Pro Panorama September 18 edition: India's FMCG demand slowdown could be a canard, long-term analysis reveals dee...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts